HFA Icon

Marty Lipton Warns Corporations To Prepare For Activist Onslaught; No One Is “Immune”

HFA Padded
Mark Melin
Published on
Updated on
Sign up for our E-mail List and Get FREE Access to Exclusive Investment E-books and More!

Activist hedge funds are partnering with institutional investors to an unprecedented degree and “no company can consider itself immune,” opined lawyer Martin Lipton, a well-known corporate advocate who operates primarily at odds with activist hedge funds. The creator of the corporate “poison pill” defense against activist overtures outlined the situation with activists and revealed how corporations might want to consider handling the challenge.

[munger]

Activist Hedge Funds

No corporation is immune from an activist challenge, and successful firms offer less risk

“No company is too large, too popular or too successful,” Lipton noted in a recent blog post on the Harvard Law Forum on Corporate Governance. “Even...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article
Already a member? Log in here
HFA Padded

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.